[HTML][HTML] Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen, S Wang… - Scientific reports, 2017 - nature.com
Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen… - Scientific …, 2017 - ui.adsabs.harvard.edu
Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen, S Wang… - Scientific Reports, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chronic kidney disease (CKD) patients have
an increased risk of cardiovascular diseases (CVDs). The present study aimed to investigate …
an increased risk of cardiovascular diseases (CVDs). The present study aimed to investigate …
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen, S Wang… - Scientific …, 2017 - europepmc.org
Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
[HTML][HTML] Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen… - Scientific …, 2017 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
KY Xu, GH Xia, JQ Lu, MX Chen, X Zhen… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …